BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4699475)

  • 1. Depression of enzymic esterification of N-hydroxy-AAF in the liver during aminoazo dye carcinogenesis in the rat.
    Blunck JM; Lees BJ
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):421-9. PubMed ID: 4699475
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo.
    Kriek E
    Cancer Res; 1972 Oct; 32(10):2042-8. PubMed ID: 5080759
    [No Abstract]   [Full Text] [Related]  

  • 3. Further evidence for two types of adducts of N-hydroxy-2-fluorenylacetamide with rat-liver proteins.
    Barry EJ; Gutmann HR
    Chem Biol Interact; 1970 Aug; 2(2):158-9. PubMed ID: 5526729
    [No Abstract]   [Full Text] [Related]  

  • 4. Sex differences in cell proliferation and N-hydroxy-2-acetylaminofluorene sulfotransferase levels in rat liver during 2-acetylaminofluorene administration.
    Jackson CD; Irving CC
    Cancer Res; 1972 Jul; 32(7):1590-4. PubMed ID: 5030584
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylmercapto-4-acetylaminostilbenes as products of the reaction of n-acetoxy-4-acetylaminostilbene with methionine and as degradation products of liver protein from rats given n-hydroxy-4-acetylaminostilbene.
    Miller EC; Butler BW; Fletcher TL; Miller JA
    Cancer Res; 1974 Sep; 34(9):2232-9. PubMed ID: 4843530
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic activation of N-hydroxy compounds by conjugation.
    Irving CC
    Xenobiotica; 1971; 1(4):387-98. PubMed ID: 5006106
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of aromatic amines with rat-liver proteins in vivo. 3. On the mechanism of binding of the carcinogens, N-2-fluorenylacetamide and N-hydroxy-2-fluorenyl-acetamide, to the soluble proteins.
    Barry EJ; Malejka-Giganti D; Gutmann HR
    Chem Biol Interact; 1969 Dec; 1(2):139-55. PubMed ID: 5407058
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactivities of the carcinogens, N-hydroxy-2-fluorenylacetamide and N-hydroxy-3-fluorenylacetamide, with tissue nucleophiles.
    Zieve FJ; Gutmann HR
    Cancer Res; 1971 Apr; 31(4):471-6. PubMed ID: 5553692
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioactivity in rat mammary gland after the administration of 2-acetylaminofluorene-9- 14 C and its N-hydroxy metabolite.
    Janss DH; Irving CC
    J Natl Cancer Inst; 1972 Sep; 49(3):765-71. PubMed ID: 4647496
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding of chemical carcinogens to nuclear proteins of rat liver.
    Jungmann RA; Schweppe JS
    Cancer Res; 1972 May; 32(5):952-9. PubMed ID: 4622840
    [No Abstract]   [Full Text] [Related]  

  • 11. On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
    Gutmann HR; Malejka-Giganti D; Barry EJ; Rydell RE
    Cancer Res; 1972 Jul; 32(7):1554-61. PubMed ID: 4337834
    [No Abstract]   [Full Text] [Related]  

  • 12. On the significance and mechanism of the binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver ribonucleic acid in vivo.
    Irving CC; Veazey RA; Williard RF
    Cancer Res; 1967 Apr; 27(4):720-5. PubMed ID: 6025731
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent binding of 2-acetylaminofluorene to rat liver DNA in vivo and consideration of the mechanism of binding of N-hydroxy-2-acetylaminofluorene to rat liver nucleic acids.
    Irving CC; Veazey RA
    Cancer Res; 1969 Oct; 29(10):1799-804. PubMed ID: 5823948
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal's gland of the rat.
    Irving CC; Janss DH; Russell LT
    Cancer Res; 1971 Apr; 31(4):387-91. PubMed ID: 5553685
    [No Abstract]   [Full Text] [Related]  

  • 15. Binding of radioactive N-hydroxy-acetylaminofluorene to synthetic polyribonucleotides.
    Marroquin F; Coyote N
    Chem Biol Interact; 1970 Aug; 2(2):151-3. PubMed ID: 5526728
    [No Abstract]   [Full Text] [Related]  

  • 16. Aromatic amine carcinogenesis: the importance of N-hydroxylation.
    Clayson DB; Dawson KM; Dean HG
    Xenobiotica; 1971; 1(4):539-42. PubMed ID: 5164806
    [No Abstract]   [Full Text] [Related]  

  • 17. The binding of N-hydroxy-2-acetylaminofluorene to replicating and non-replicating DNA in rat liver.
    Jackson CD; Irving CC
    Chem Biol Interact; 1970 Oct; 2(3):261-5. PubMed ID: 5524166
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of aminoazo dyes on drug metabolism in rat liver.
    Baldwin RW; Barker CR
    Br J Cancer; 1965 Sep; 19(3):565-72. PubMed ID: 4953572
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic activation of N-hydroxy-N,N'-diacetylbenzidine by hepatic sulfotransferase.
    Morton KC; Beland FA; Evans FE; Fullerton NF; Kadlubar FF
    Cancer Res; 1980 Mar; 40(3):751-7. PubMed ID: 6937241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-N-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver.
    Bartsch H; Dworkin M; Miller JA; Miller EC
    Biochim Biophys Acta; 1972 Dec; 286(2):272-98. PubMed ID: 4660457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.